首页 > 市场调查报告书 > 製药

疫苗

市场调查报告书

商品编码

1699441

减毒活疫苗市场按产品类型、技术、适应症、给药方式、年龄层、分销管道和地区划分

Life Attenuated Vaccines Market, By Product Type, By Technology, By Indication, By Mode of Administration, By Age Group, By Distribution Channel, By Geography

出版日期: 2025年03月04日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球减毒活疫苗市场规模估计为 295 亿美元，预计到 2032 年将达到 632.1 亿美元，2025 年至 2032 年复合年增长率为 11.5%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	295亿美元
效能资料	从2020年到2024年	预测期	2025-2032
预测期：2025-2032年复合年增长率：	11.50%	2032年价值预测	632.1亿美元

数字。减毒活疫苗市场占有率（%），依地区划分（2025年）

减毒活疫苗使用减毒或死亡的活微生物或病原体来诱导免疫。当这些疫苗给患者註射时，它们会模拟自然感染，但不会引起疾病。常见的减毒活疫苗包括麻疹、腮腺炎、德国德国麻疹(MMR)、水痘、轮状病毒和黄热病疫苗。预计在预测期内，全球预防性医疗保健意识的提高和疫苗接种计划的增加将推动该市场的成长。

市场动态：

预计新兴国家政府对疫苗接种计划的投资增加将在预测期内推动市场成长。此外，麻疹、流行性腮腺炎和德国德国麻疹等各种疾病发生率的上升也进一步推动了对减毒活疫苗的需求。然而，疫苗开发高成本、核准规定严格是限制市场成长的主要因素。另一方面，针对新兴疾病的疫苗研发工作正在进行中，新型减毒疫苗的核准可能为市场参与企业带来具有吸引力的成长机会。

本研究的主要特点

本报告对全球减毒活疫苗市场进行了详细分析，并提供了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%），假设 2024 年为基准年。

它还强调了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。

该报告根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，概述了全球减毒活疫苗市场的主要企业。

主要企业包括葛兰素史克公司、默克公司、辉瑞公司、安斯泰来製药公司、强生公司、CSL 有限公司、Emergent BioSolutions、MedImmune, LLC、赛诺菲、印度血清研究所。 Ltd.、Bharat Biotech、武田製药公司、诺华公司、BioNTech SE、科兴生物科技有限公司

本报告提供的见解将帮助负责人和企业经营团队未来的产品发布、升级、市场扩张和行销策略做出明智的决策。

本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

相关人员可以透过用于分析全球减毒活疫苗市场的各种策略矩阵来促进他们的决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 29.50 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	11.50%	2032 Value Projection:	USD 63.21 Bn

Life attenuated vaccines use weakened or attenuated live microorganisms or pathogens to trigger immunity. When administered to a patient, these vaccines mimic a natural infection but do not cause the disease. Common life attenuated vaccines include measles, mumps, rubella (MMR), varicella, rotavirus, and yellow fever vaccines. Growing awareness regarding preventive healthcare and rising immunization programs worldwide are expected to support the growth of this market over the forecast period.

Market Dynamics:

Increasing investments by government bodies in immunization programs across developing nations are expected to drive the market growth during the forecast period. Moreover, rising incidence of various diseases, such as measles, mumps, and rubella, is further propelling the demand for life attenuated vaccines. However, high costs associated with vaccine development and stringent regulations for approval are the major factors anticipated to restrain the market growth. On the flip side, ongoing research & development activities to develop vaccines for new diseases and approval of newer attenuated vaccines are likely to present attractive growth opportunities for the players in the market.

Key Features of the Study:

This report provides in-depth analysis of the global life attenuated vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global life attenuated vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include GlaxoSmithKline plc, Merck & Co., Pfizer, Inc., Astellas Pharma Inc., Johnson & Johnson, CSL Limited, Emergent BioSolutions, Inc., MedImmune, LLC, Sanofi, Serum Institute of India Pvt. Ltd., Bharat Biotech, Takeda Pharmaceutical Company, Novartis AG, BioNTech SE, and Sinovac Biotech Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global life attenuated vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global life attenuated vaccines market

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Bacterial
- Viral
Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Classical Techniques
- Live Attenuation
- Inactivated/Killed
- Advanced Techniques
- Recombinant DNA Technology
- Viral Vector Technology
Indication Insights (Revenue, USD Bn, 2020 - 2032)
- Tuberculosis
- Measles
- Rotavirus
- Yellow Fever
- Oral Polio
- Others
Mode of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Injectable
- Intranasal
- Oral
- Others
Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric Vaccines
- Adult Vaccines
- Geriatric Vaccines
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- GlaxoSmithKline plc
- Merck & Co.
- Pfizer, Inc.
- Astellas Pharma Inc.
- Johnson & Johnson
- CSL Limited
- Emergent BioSolutions, Inc.
- MedImmune, LLC
- Sanofi
- Serum Institute of India Pvt. Ltd.
- Bharat Biotech
- Takeda Pharmaceutical Company
- Novartis AG
- BioNTech SE
- Sinovac Biotech Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Life Attenuated Vaccines Market, By Product Type
- Global Life Attenuated Vaccines Market, By Technology
- Global Life Attenuated Vaccines Market, By Indication
- Global Life Attenuated Vaccines Market, By Mode of Administration
- Global Life Attenuated Vaccines Market, By Age Group
- Global Life Attenuated Vaccines Market, By Distribution Channel
- Global Life Attenuated Vaccines Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Life Attenuated Vaccines Market, By Product Type, 2025-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Bacterial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Viral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Life Attenuated Vaccines Market, By Technology, 2025-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Classical Techniques
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Live Attenuation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Inactivated/Killed
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Advanced Techniques
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Recombinant DNA Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Viral Vector Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Life Attenuated Vaccines Market, By Indication, 2025-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Tuberculosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Measles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Rotavirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Yellow Fever
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oral Polio
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Life Attenuated Vaccines Market, By Mode of Administration, 2025-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intranasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Life Attenuated Vaccines Market, By Age Group, 2025-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Adult Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Geriatric Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Life Attenuated Vaccines Market, By Distribution Channel, 2025-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Life Attenuated Vaccines Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mode of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mode of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mode of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mode of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
Africa
- South Africa
- North Africa
- Central Africa

11. Competitive Landscape

GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co.
Pfizer, Inc.
Astellas Pharma Inc.
Johnson & Johnson
CSL Limited
Emergent BioSolutions, Inc.
MedImmune, LLC
Sanofi
Serum Institute of India Pvt. Ltd.
Bharat Biotech
Takeda Pharmaceutical Company
Novartis AG
BioNTech SE
Sinovac Biotech Ltd.

12. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

13. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

减毒活疫苗市场按产品类型、技术、适应症、给药方式、年龄层、分销管道和地区划分